Home > Insider Trading > Filing (0000950170-23-031207)

Filing Details

Accession Number:: 0000950170-23-031207
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-30 18:29:14
Reporting Period:: 2023-06-28

Accepted Time:: 2023-06-30 18:29:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1816736	Disc Medicine Inc.	IRON	Pharmaceutical Preparations (2834)	851613057

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1952556	Richard Brian Macdonald	C/O Disc Medicine, Inc. 321 Arsenal Street, Suite 101 Watertown MA 02472	Chief Innovation Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-06-28	2,247	$49.24	25,153	No	4	S	Direct
Common Stock	Disposition	2023-06-28	1,900	$50.38	23,253	No	4	S	Direct
Common Stock	Disposition	2023-06-28	953	$50.80	22,300	No	4	S	Direct
Common Stock	Disposition	2023-06-29	736	$44.37	21,564	No	4	S	Direct
Common Stock	Disposition	2023-06-29	2,230	$45.49	19,334	No	4	S	Direct
Common Stock	Disposition	2023-06-29	1,934	$46.51	17,400	No	4	S	Direct
Common Stock	Disposition	2023-06-29	200	$47.24	17,200	No	4	S	Direct
Common Stock	Disposition	2023-06-30	2,923	$44.85	14,277	No	4	S	Direct
Common Stock	Disposition	2023-06-30	1,401	$45.45	12,876	No	4	S	Direct
Common Stock	Acquisiton	2023-06-30	600	$46.76	12,276	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,096	Indirect	Held by Son
Common Stock	1,096	Indirect	Held by Son
Common Stock	1,096	Indirect	Held by Son

Footnotes

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 17, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.61 to $49.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.61 to $50.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.62 to $51.235, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.87, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.03 to $45.94, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.04 to $46.96, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.25, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.31 to $45.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.31 to $45.58, inclusiv
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.56 to $47.00, inclusive.
The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.